Pharmacological analysis of [3H]‐senktide binding to NK3tachykinin receptors in guinea‐pig ileum longitudinal muscle‐myenteric plexus and cerebral cortex membranes

Authors:

Abstract
The binding properties and pharmacological specificity of the selective NK3tachykinin receptor agonist [3H]‐senktide ([3H]‐succinyl[Asp6,MePhe8] substance P (6–11)) have been examined in homogenates of guinea‐pig ileum longitudinal muscle‐myenteric plexus (LM/MP) and cerebral cortex. Scatchard analysis of saturation binding studies in guinea‐pig ileum LM/MP and cerebral cortex membranes indicated that [3H]‐senktide bound to a single site with apparent high affinity,KD= 2.21 ± 0.65 nm;Bmax= 13.49 ± 0.04 fmol mg−1protein in ileum andKD= 8.52 ± 0.45 nm;Bmax= 76.3 ± 1.6 fmol mg−1protein in cortex (values are means ± ranges;n= 2). The pharmacological profile for tachykinins and analogues in displacing [3H]‐senktide from ileum membranes was: [MePhe7] neurokinin B > neurokinin B (NKB) ≃ senktide > eledoisin > substance P (SP) > neurokinin A(NKA) > physalaemin > [Sar9,Met(O2)11]SP > [Nle10]NKA(4–10) = [Glp6,L‐Pro9]‐SP(6–11) > substance P methyl ester, consistent with [3H]‐senktide binding to an NK3subtype of tachykinin receptor. A similar rank order of affinity was obtained for these peptides in displacing [3H]‐senktide from cortex membranes Several tachykinin receptor agonists were tested for their ability to displace [3H]‐senktide from ileal and cortical NK3binding sites and were found to be either weak displacers (pIC50< 5.00) or inactive. The binding of [3H]‐senktide to cortex membranes was inhibited by GTP (pIC50= 6.49)and GTP‐γ‐S (pIC50= 6.67) with ATP being at least three orders of magnitude less potent (pIC50= 3.55). These results indicate that both central and peripheral NK3receptors share a similar pharmacological specificity and that they may be labelled selectively with the NK3receptor agonist [3H]‐senktide.

This publication has 36 references indexed in Scilit: